Searching for Magic Bullets: Orphan Drugs, Consumer Activism, and Pharmaceutical DevelopmentCRC Press, 1994 M08 10 - 266 pages Searching for Magic Bullets reveals the quest of consumers, health professionals, and drug developers to find safer and faster methods of bringing new medications to the marketplace. Authors Basara and Montagne explore the current drug development and approval processes, their strengths and weaknesses, and the mechanisms by which patients and organizations evade these processes. Readers learn about the fundamentals of traditional and nontraditional drug discovery and development as they occur in the U.S., as well as the views of consumers, patients, and health professionals. Specific case studies of non-traditional drug development and acquisition strategies are highlighted, including AIDS medications, orphan drugs, and patient importation of medications.Basara and Montagne establish the differences in both knowledge and opinions of health consumers and health professionals regarding drug development, as well as how these differences often lead to frustration, dissatisfaction, and misappropriation of resources. The authors pinpoint the need for consumers and patients to know much more about the discovery and development of medicines, and for health professionals and students to understand patients’concerns, needs and beliefs, including their reasons for considering alternative methods of drug development and acquisition. Searching for Magic Bullets is a springboard from which consumers, health professionals, and students can discuss, debate, and resolve these issues and begin to develop more capable drug development and approval systems.This groundbreaking new book enlightens health professionals about patients’views regarding medication discovery and development and informs consumers and patients about the sometimes conflicting views of health professionals. It is divided into three sections: drug development and approval in the U.S., a case study of orphan drugs, and risky and sometimes illegal ways in which consumers evade the traditional drug development and approval systems. An Overview of the Chapters:
|
Contents
History of Drug Discovery | 1 |
The Pharmaceutical Industry in Early America | 11 |
History of Pharmaceutical Marketing | 17 |
A Summary of the Past and a Look to the Future | 23 |
Societal Perceptions and Acceptance of | 36 |
Quality of Drug Information | 42 |
The Food and Drug Administration and Drug | 77 |
The Basic DrugApproval Process | 85 |
Current Orphan Drug Controversies | 165 |
The AIDS Crisis | 174 |
Searching for the Magic Bullet | 180 |
PatientDirected Studies and Other Alternatives | 186 |
Nontraditional and Underground Drug | 193 |
Drug Diversion and Nontraditional Drug Distribution | 202 |
Problems Resulting from Nontraditional Drug | 211 |
Empowering Consumers and HealthCare | 217 |
Other editions - View all
Searching for Magic Bullets: Orphan Drugs, Consumer Activism, and ... Lisa A Basara,Michael E Montagne No preview available - 1994 |
Common terms and phrases
activities adverse AIDS patients alglucerase amendments American Anonymous Association benefits biopharmaceuticals biotechnology cancer Chapter chemical clinical drug trials clinical trial compounds concerns consumers costs cure didanosine distribution Drug Administration drug advertising drug application drug development drug discovery drug information drug products drug research drug-approval process drug's efficacy erythropoietin ethical evaluated experimental Food and Drug Gaucher's disease health professionals health-care professionals health-care system human illegal important individual investigational new drug issues labeling life-threatening Medicine ment minimize National nonprescription Nootropic number of patients organizations orphan diseases Orphan Drug Act pharmaceutical companies pharmaceutical industry pharmaceutical manufacturers pharmacist Pharmacy Phase physicians placebo potential prescription drugs problems promotion rare diseases rare disorder receive regulations Reports research and development safety and effectiveness scientific smart drugs sources specific sponsor substances sumers symptoms syndrome TABLE testing therapeutic tion treat treatment York zidovudine